Lisa Wilson | In-Site Communications, IR |
Patrick Walsh | Interim President and CEO |
Stephen Carey | CFO |
Brandon Folkes | Cantor Fitzgerald |
Dana Flanders | Guggenheim |
Good morning, everyone, and welcome to ANI's Second Quarter 2020 Earnings Conference Call. [Operator Instructions] Please note this call may be recorded. It is now my pleasure to turn today's program over to Lisa Wilson, Investor Relations for ANI Pharmaceuticals. Ms. Wilson, please go ahead.